34.31 USD
↗ 1.08 (3.25%)AT CLOSE (11:59 AM EDT)
Indivior Pharmaceuticals, Inc. Common Stock
INDVNASDAQ • USD
35.42
↗ 1.11 (3.24%)
POST MARKET (AS OF 06:47 PM EDT)
Post Market
AS OF 06:47 PM EDT
35.42
↗ 1.11 (3.24%)
Market: CLOSED
Open?$33.30
High?$35.34
Low?$33.30
Prev. Close?$33.23
Volume?2.8M
Avg. Volume?2.6M
VWAP?$34.31
Rel. Volume?1.10x
Bid / Ask
Bid?$34.34 × 200
Ask?$36.50 × 200
Spread?$2.16
Midpoint?$35.42
Valuation & Ratios
Market Cap?4.1B
Shares Out?121.9M
Float?114.6M
Float %?91.8%
P/E Ratio?19.39
P/B Ratio?-40.92
EPS?$1.71
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.71Weak
Quick Ratio?0.55Weak
Cash Ratio?0.21Low
Debt/Equity?-3.22Low
ValuationFAIRLY VALUED
Score73/100
P/E?19.4FAIR▾
P/B?-40.92CHEAP▾
P/S?3.27FAIR▾
P/FCF?N/A▾
EV/EBITDA?15.2FAIR▾
EV/Sales?3.37FAIR▾
Returns & Efficiency
ROE?-211.1%WEAK▾
ROA?17.4%STRONG▾
Cash Flow & Enterprise
FCF?$-93000000
Enterprise Value?$4.2B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Employees
838
Market Cap
4.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-12-24
Address
10710 MIDLOTHIAN TURNPIKE
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090